RECBIO-B (02179) Stock Price, News, Quotes-Moomoo

HK Stock MarketDetailed Quotes

02179 RECBIO-B

Watchlist

8.220
-0.320-3.75%

Not Open Nov 1 16:08 CST

3.97BMarket Cap-6607P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Jiangsu Recbio Technology Initiates Phase III Clinical Trials for Shingles Vaccine
MT NewswiresOct 23 02:20 ET
RECBIO-B: 2024 Interim Report
HKEXSep 26 05:19 ET · Announcements
Jiangsu Recbio Technology Co., Ltd. (HKG:2179) Surges 12%; Individual Investors Who Own 24% Shares Profited Along With Institutions
Simply Wall StAug 23 18:47 ET
Express News | Jiangsu Recbio Technology - Hy Loss Attributable RMB247.7 Mln Vs Loss RMB269.1 Mln
ReutersAug 20 08:58 ET
Express News | Jiangsu Recbio Technology H1 Capex RMB 78.1 Million
ReutersAug 20 08:56 ET
RECBIO-B: UNAUDITED INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
HKEXAug 20 08:56 ET · Announcements

Comments

Spinee

Dec 14, 2022 02:59

Vaccine Makers Shoot up as CN Unveils Implementation Plan for Covid Vaccine Booster Shots

Specifically, a second booster shot will be administered to people from high-risk groups, citizens older than 60, patients with chronic fundamental diseases and those with compromised immune systems.
Hong Kong-listed vaccine makers, buoyed by the news, broadly shot up. $CANSINOBIO (06185.HK)$rose 6.6% to $90.6, on a volume of 9.0554 million shares, involving $801 million. $RECBIO-B (02179.HK)$ , $INNOCARE (09969.HK)$ and ...